The article addresses ethical concerns about the limited conduct of randomized clinical trials (RCTs) during pregnancy. Dr. Bilinski highlights the importance of expanding evidence on medication use during pregnancy. The author emphasizes that the main limitations in conducting these studies are methodological in nature. Expanding evidence on the safety and efficacy of medicines in pregnancy is crucial for improving care for pregnant women. The article points to the need to address methodological challenges in research involving this population.